IRM Lags Peers as Options Traders Turn Defensive Before November Print

Iron Mountain fell 2.3% over the past week while its closest data-center REIT peers held or gained ground: DLR slipped just 2%, EQIX dropped 3.1%, and storage-adjacent names CUBE and MRP added 3% and 6% respectively. Iron Mountain's underperformance is modest in isolation, but it arrives at an uncomfortable moment: the stock closed at $109.96 on Friday, roughly 22% below the Street's mean price target of $144, and the November 5 earnings date is now twelve days away.

The clearest shift this week is in options positioning, which has turned meaningfully more defensive. The put/call ratio reached 1.79 on Thursday, more than two standard deviations above its 20-day average of 1.39 and the highest defensive reading in months. That is a sharp reversal from the note published a week ago, when the ratio had eased to 1.28 and appeared to be normalising after a period of elevated protection-buying through September. The reversal is worth flagging: the ratio has climbed every session this week, and at 1.79 it is now approaching the 52-week peak of 2.42. Put buyers are not panicking, but they are noticeably more active than they were seven days ago.

The lending market, by contrast, has barely moved. Short interest is 2.46% of the free float, effectively unchanged on the week after a brief tick higher earlier in October. Availability has widened further to nearly 5,975%, up from around 5,559% a week ago, meaning there is no meaningful demand pressure in the borrow market. Borrowing costs nudged up to 0.52% but remain negligible. The ORTEX short score sits at 35.9, roughly mid-range, and has been stable all week. There is no short-side crowding story here: the borrow market is loose, positioning is low, and the short score gives no signal of a building squeeze or a significant short build.

The Street has spent most of 2026 steadily lifting targets, with multiple firms raising through the summer. Barclays moved to $144 in September, Truist went to $155 in August, and Rothschild initiated at $132 with a Buy in late September. The direction of analyst travel has been consistently upward and the consensus remains constructive. Valuation is less straightforward: the stock trades at roughly 41 times trailing earnings and 16 times EV/EBITDA, with an earnings yield ranking in the 24th percentile of its universe. The EV/EBITDA multiple has compressed modestly over the past 30 days, which in a rising-target environment points more to price weakness than to any deterioration in the underlying numbers. EPS momentum scores are strong, ranking in the 82nd percentile on a 90-day basis.

Insider activity is a less encouraging signal. The SEC Form 4 record shows CEO William Meaney sold shares on three separate transactions on October 1, disposing of a combined 38,468 shares for around $4.25 million. The Chief Commercial Officer sold a further 5,000 shares the same day. All transactions were executed under pre-arranged 10b5-1 plans, which strips out some of the discretionary read, but the net insider position over the past 90 days runs to a disposal of roughly 149,000 shares worth $17.4 million. Planned sales are a routine feature of executive compensation programmes, and the 10b5-1 label matters here, but the scale is notable context ahead of a print.

The one metric to track before November 5 is whether the put/call ratio keeps climbing toward the 52-week high of 2.42 or stabilises. The last two earnings reactions were modest: a 2.8% decline the day after the August print and a 1.3% gain on the July event. Whether that pattern holds, and how the gap between the current price and the $144 analyst consensus responds to the next set of numbers, is what frames the setup from here.